EQGen Biomedical
PrivateLast Round
Seed
Apr 24, 2025
Total Funding Raised
$3.7M
Company Overview
EQGen Biomedical operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Seed round in April 2025.
EQGen Biomedical is a biotechnology company that develops regenerative stem cell therapies for the treatment of musculoskeletal diseases in animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EQGen Biomedical Comparables
Compare EQGen Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| eQcell Inc. | 86% | |
| Qentoros, Inc. | 83% | |
| EquiCord | 82% |
For institutional investors. Book with your work email.
EQGen Biomedical Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2025
$4M raised from Grant Senner and Willem Scheele.
For institutional investors. Book with your work email.
EQGen Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EQGen Biomedical's valuation, stock price, and market status.
Is EQGen Biomedical a public or private company?
EQGen Biomedical is a private company.
What is the current stock price of EQGen Biomedical?
EQGen Biomedical is a private company, so its shares have no public market price. Caplight tracks EQGen Biomedical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EQGen Biomedical worth (valuation)?
Valuation information for EQGen Biomedical is not publicly available.
Can I buy EQGen Biomedical stock?
EQGen Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EQGen Biomedical's last funding round?
EQGen Biomedical's most recent funding round was Seed on April 24, 2025.
Who are the main investors in EQGen Biomedical?
Investor information for EQGen Biomedical is not publicly disclosed.
Will EQGen Biomedical IPO soon?
No public IPO plans have been announced for EQGen Biomedical.
How can I track EQGen Biomedical secondary market activity?
Caplight tracks bids, offers, and trades in EQGen Biomedical's shares on secondary markets.